Lv71
4980 积分 2021-03-01 加入
The epidemiology of glucocorticoid-associated adverse events
5小时前
待确认
糖皮质激素在临床应用中的不良反应及预防策略
6小时前
待确认
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
3天前
已完结
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
3天前
已完结
Major adverse cardiovascular events among patients with type 2 diabetes mellitus: A prospective study
7天前
已关闭
Inclisiran versus alirocumab in improving lipid profile parameters: A systematic review and meta-analysis
7天前
已完结
Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database
25天前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
25天前
已完结
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
25天前
已完结
Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care
27天前
已关闭
皖公网安备34019202002308
